Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
Could This Be the Cure? Targeting Protein Imbalances To Stop Alzheimer’s
Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...
World’s largest proteins study ‘invaluable’ for understanding disease – experts
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...
Genetic changes in brain cells link aging and Alzheimer's
Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...
Dementia diagnosis: How long do patients really live?
The average life expectancy of people diagnosed with dementia ranges from nine years at age 60 to 4.5 years at age 85 for ...
Common drug backed by celebs and taken by millions could raise Alzheimer's risk, British researchers discover
Use of the treatment has soared in popularity in recent years now taken by 2.6million women in England according to the ...